IP Library Granted Patent US 11,590,010
Granted Patent B2
US 11,590,010 · App. 15/875,194 · Granted Feb 28, 2023

Methods and systems for facilitating laminar flow between conduits

Inventors: Craig Nordhausen (Salt Lake City, UT); John William Hall (North Salt Lake, UT)
Assignee: Merit Medical Systems, Inc.
A61F2/915A61F2/07A61F2/954A61F2/958A61M25/1018A61F2/97A61F2002/075A61F2002/91508A61F2002/9583A61F2250/006A61F2250/0039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,590,010
App. No.
15/875,194
Granted
Feb 28, 2023
Kind
B2
Abstract

Medical devices including vascular access kits and related system and methods are disclosed. In some embodiments, a vascular access system may include a first conduit, a second conduit, and an expandable stent that is coupled to both the first and second conduits such that there is a continuous lumen between the first conduit and the second conduit. Methods of deploying the vascular access system within the body of a mammal, more particularly, a human patient are disclosed. Methods of bypassing a section of vasculature of a mammal, more particularly, a human patient are disclosed. The vascular access system, when implanted and assembled, may be a fully subcutaneous surgical implant.

Claims (20)

1. A vascular access system, comprising: a first conduit comprising a second central end;

a second conduit comprising a first central end;

an expandable stent configured to be deployed to couple to the second central end of the first conduit and to the first central end of the second conduit; and

a first pull sting operably coupled to the expandable stent and configured to allow expansion of the expandable stent when pulled,

wherein in an expanded configuration, a first portion of the expandable stent is disposed within the second central end of the first conduit so that an outer surface of the first portion is in contact with an inner surface of the first conduit and a second portion of the expandable stent is disposed within the first central end of the second conduit so that an outer surface of the second portion is in contact with an inner surface of the second conduit, such that there is a fluid-tight continuous lumen from the first conduit to the second conduit,

wherein one or both of the first conduit and the second conduit is configured to be accessed extravascularly for hemodialysis, and

wherein the expandable stent is a self-expanding stent.

2. The vascular access system of claim 1 , wherein the expandable stent is coupled to the first conduit before being deployed to couple to the second conduit.

3. The vascular access system of claim 2 , wherein either the stent or the stent coupled to the first conduit is configured for delivery through a lumen of a deployment device.

4. The vascular access system of claim 1 , wherein the first conduit, the second conduit, or the stent comprise a fibrous polymer.

5. The vascular access system of claim 1 , wherein one or both of the first conduit and the second conduit comprise a puncturable and self-sealing wall material such that the wall material may be punctured by insertion of a needle and then reseal upon withdrawal of the needle.

6. The vascular access system of claim 1 , wherein the expandable stent is pre-coupled to either the first conduit or the second conduit.

7. The vascular access system of claim 6 , wherein the expandable stent is pre-coupled to the first or the second conduit via a collar.

8. The vascular access system of claim 6 , wherein the expandable stent is pre-coupled to the first or the second conduit through the manufacturing process.

9. The vascular access system of claim 1 , further comprising a first therapeutic agent that is associated with one or both of an inner luminal surface and an outer abluminal surface of any of the first conduit, the second conduit, or the expandable stent of the vascular access system, wherein the vascular access system is configured to deliver a therapeutically effective dose of the first therapeutic agent to a patient when the vascular access system is implanted within the patient.

10. The vascular access system of claim 1 , wherein the expandable stent is configured to maintain the position the expandable stent was deployed in the first conduit and the second conduit.

11. The vascular access system of claim 10 , wherein a length of the expandable stent is sufficient to maintain the position the expandable stent was deployed in the first conduit and the second conduit.

12. The vascular access system of claim 11 , wherein the expandable stent comprises anchors configured to maintain the position the expandable stent was deployed in the first conduit and the second conduit.

13. The vascular access system of claim 1 , further comprising a second pull string operably coupled to the expandable stent, wherein the first pull string is configured to allow expansion of the first portion of the expandable stent when pulled and the second pull string is configured to allow expansion of the second portion of the when pulled.

14. The vascular access system of claim 12 , wherein the anchors are barbs with an outward radial force.

Assignments (2)
SECURITY INTEREST Recorded Aug 28, 2018
From: MERIT MEDICAL SYSTEMS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 046957/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2018
From: NORDHAUSEN, CRAIG; HALL, JOHN WILLIAM
To: MERIT MEDICAL SYSTEMS, INC.
Reel/Frame 045301/0220 →
Continuity (2)
Provisional Application 62450219 · Jan 25, 2017
Related Publication 20180207009A1 · Jul 26, 2018